GLIBA compared with PDSB: revenue, margins and what each company keeps, and the suppliers and customers both name

GLIBALiberty Capital Corp

Mkt capRevenueRevenue

PDSBPDS Biotechnology Corp

Mkt capRevenueRevenue

Compare

GLIBALiberty Capital Corp

PDSBPDS Biotechnology Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

GLIBA, solidPDSB, dashed

Supply-chain overlap

Revenue flow

PDSB: latest quarter not drawable.Method ›

GLIBALiberty Capital Corp

21.45▼−0.26%· post 22.50

Mkt cap$897.1MRevenue$261MQ2 FY26

PDSBPDS Biotechnology Corp

1.43▼−7.74%· post 1.46

ClosedOct 30 '26

Mkt cap$80.6MRevenue—

Compare

ClosedOct 30 '26

GLIBALiberty Capital Corp

PDSBPDS Biotechnology Corp

21.45▼−0.26%post 22.50

Price

1.43▼−7.74%post 1.46

$897.1M

Mkt cap

$80.6M

Q2 FY26$261M

Revenue

—

GLIBA21.45▼−0.26%vsPDSB1.43▼−7.74%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GLIBA 0

None

Shared 0

No disclosed counterparties: GLIBA.

Only PDSB 2

MRKMerckcustomer

—NCIunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR